NOT-HL-24-006: Notice of NHLBI Participation in PA-24-141 "NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)"

Notice of NHLBI Participation in PA-24-141 "NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)"

Notice Number:

NOT-HL-24-006

Key Dates

Release Date:

March 8, 2024

Related Announcements

March 6, 2024 - “NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)". See NOFO PA-24-141 .

Issued by

National Heart, Lung, and Blood Institute (NHLBI)

Purpose

The purpose of this Notice is to inform potential applicants that effective immediately the National Heart, Lung, and Blood Institute (NHLBI) will participate in PA-24-141 “NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)" issued by the National Institutes of Health.

The following text has been added to reflect NHLBI's participation:

Part 1. Overview Information

Components of Participating Organizations

National Heart, Lung, and Blood Institute (NHLBI)

Catalog of Federal Domestic Assistance (CFDA) Number(s)

93.837, 93.838, 93.839, 93.840, 93.233

All other aspects of the NOFO remain the same.

Inquiries

Please direct all inquiries to:

Please direct all inquiries regarding this Notice of Participation to:

National Heart, Lung, and Blood Institute (NHLBI)
Email: NHLBI_R13@nhlbi.nih.gov